These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7829768)

  • 41. Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective disorders.
    Bauer M; Blumentritt H; Finke R; Schlattmann P; Adli M; Baethge C; Bschor T; Müller-Oerlinghausen B; Berghöfer A
    J Affect Disord; 2007 Dec; 104(1-3):45-51. PubMed ID: 17346802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The lithium loading dose method in a clinical setting.
    Fava GA; Molnar G; Block B; Lee JS; Perini GI
    Am J Psychiatry; 1984 Jun; 141(6):812-3. PubMed ID: 6428242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cortisol changes in long-term lithium therapy.
    Smigan L; Perris C
    Neuropsychobiology; 1984; 11(4):219-23. PubMed ID: 6436729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
    Goldberg JF; Harrow M
    J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Who responds to prophylactic lithium?
    Abou-Saleh MT; Coppen A
    J Affect Disord; 1986; 10(2):115-25. PubMed ID: 2941468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lithium prophylaxis of manic-depressive disorder: daily lithium dosing schedule versus every second day.
    Jensen HV; Plenge P; Mellerup ET; Davidsen K; Toftegaard L; Aggernaes H; Bjørum N
    Acta Psychiatr Scand; 1995 Jul; 92(1):69-74. PubMed ID: 7572251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lithium treatment: a comparison of once- and twice-daily dosing.
    Abraham G; Delva N; Waldron J; Lawson JS; Owen J
    Acta Psychiatr Scand; 1992 Jan; 85(1):65-9. PubMed ID: 1546552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Connection between lithium and muscular incoordination.
    Grounds D
    Aust N Z J Psychiatry; 2002 Feb; 36(1):142-3. PubMed ID: 11929455
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of lithium on glycine levels in patients with affective disorders.
    Deutsch SI; Peselow ED; Banay-Schwartz M; Gershon S; Virgilio J; Fieve RR; Rotrosen J
    Am J Psychiatry; 1981 May; 138(5):683-4. PubMed ID: 6786113
    [No Abstract]   [Full Text] [Related]  

  • 52. Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables.
    Maj M; Del Vecchio M; Starace F; Pirozzi R; Kemali D
    Acta Psychiatr Scand; 1984 Jan; 69(1):37-44. PubMed ID: 6422702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial.
    Kleindienst N; Severus WE; Greil W
    Int Clin Psychopharmacol; 2007 May; 22(3):125-31. PubMed ID: 17414737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New applications of lithium therapy.
    Murray JB
    J Psychol; 1990 Jan; 124(1):55-73. PubMed ID: 2108242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What do patients in a lithium outpatient clinic know about lithium therapy?
    Schaub RT; Berghoefer A; Müller-Oerlinghausen B
    J Psychiatry Neurosci; 2001 Sep; 26(4):319-24. PubMed ID: 11590971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years.
    Berghöfer A; Kossmann B; Müller-Oerlinghausen B
    Acta Psychiatr Scand; 1996 May; 93(5):349-54. PubMed ID: 8792904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Lithium in periodic psychoses. Report on 10 years in 34 persons].
    Beloncle M; Martin A; Masson JM; Voisinet C
    Ann Med Psychol (Paris); 1982 Mar; 140(3):369-74. PubMed ID: 6814321
    [No Abstract]   [Full Text] [Related]  

  • 60. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
    Narendran R; Young CM; Valenti AM; Pristach CA; Pato MT; Grace JJ
    J Clin Psychiatry; 2001 Jul; 62(7):509-16. PubMed ID: 11488360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.